Inventor · disambiguated record
Emmanuel Hubert Demont
Also filed as: DEMONT EMMANUEL · DEMONT EMMANUEL H · DEMONT EMMANUEL HUBERT
24 granted patents·10 pending applications·199 citations·filing 2002–2019
94Inventor score
Files withGLAXOSMITHKLINE IP NO 2 LTD12DEMONT EMMANUEL HUBERT5AMANS DOMINIQUE3BAILEY JAMES MATTHEW3DEMONT EMMANUEL H3
Top patents by PatentIndex Score
34 records- 0193US7253198B2Hydroxyethylamine derivatives for the treatment of Alzheimer's diseaseGLAXO GROUP LTD·Filed 2003·Granted Aug 7, 2007·70 cites·16 claims
- 0292US9067936B24-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorDEMONT EMMANUEL HUBERT·Filed 2012·Granted Jun 30, 2015·18 cites·12 claims
- 0392US8580957B2Thetrahydroquinolines derivatives as bromodomain inhibitorsDEMONT EMMANUEL HUBERT·Filed 2010·Granted Nov 12, 2013·29 cites·19 claims
- 0489US9029395B2Tetrahydroquinoline derivatives useful as bromodomain inhibitorsAMANS DOMINIQUE·Filed 2012·Granted May 12, 2015·17 cites·17 claims
- 0589US8697725B2Tetrahydroquinoline derivatives and their pharmaceutical useDEMONT EMMANUEL HUBERT·Filed 2010·Granted Apr 15, 2014·19 cites·17 claims
- 0688US9315487B2Tetrahydroquinoline derivatives useful as bromodomain inhibitorsAMANS DOMINIQUE·Filed 2012·Granted Apr 19, 2016·16 cites·8 claims
- 0788US8993554B2Tetrahydroquinoline derivatives useful as bromodomain inhibitorsAMANS DOMINIQUE·Filed 2012·Granted Mar 31, 2015·17 cites·16 claims
- 0885US10370356B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Aug 6, 2019·6 cites·20 claims
- 0979US10583112B2Benzo[b]furans as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 10, 2020·2 cites·22 claims
- 1076US10428026B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Oct 1, 2019·2 cites·25 claims
- 1173US10966961B2Pyrazole derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Apr 6, 2021·1 cites·17 claims
- 1272US9416130B24-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2015·Granted Aug 16, 2016·1 cites·7 claims
- 1372US8222245B2Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)DEMONT EMMANUEL HUBERT·Filed 2008·Granted Jul 17, 2012·1 cites·5 claims
- 1466US10927080B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Feb 23, 2021·0 cites·8 claims
- 1561US9861627B24-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2017·Granted Jan 9, 2018·0 cites·6 claims
- 1658US9610284B24-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2016·Granted Apr 4, 2017·0 cites·16 claims
- 1754US2021346336A1Furan derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Application pending·0 cites
- 1850US11273146B2Benzofuran derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Mar 15, 2022·0 cites·21 claims
- 1947US2007073060A1Tricycle indole hydroxyethlamine derivatives and their use in the treatment of alzheimer's diseaseDEMONT EMMANUEL H·Filed 2004·Application pending·0 cites
- 2046US2006229302A1Tricyclic indole derivatives and their use in the treatment of alzheimer's diseaseDEMONT EMMANUEL H·Filed 2004·Application pending·0 cites
- 2146US2011046137A1Pyrazole Derivatives as P2X7 ModulatorsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2245US11319307B22,3-dihydrobenzohurans as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted May 3, 2022·0 cites·18 claims
- 2345US10849897B2Pyridyl derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Dec 1, 2020·0 cites·20 claims
- 2445US2006211740A1Novel compoundsDEMONT EMMANUEL H·Filed 2004·Application pending·0 cites
- 2544US6632826B1Carbocyclic HIV protease inhibitorsHOFFMANN LA ROCHE·Filed 2002·Granted Oct 14, 2003·0 cites·8 claims
- 2643US2009149524A1N-(Phenylmethyl)-2-(1H-Pyrazol-4-yl) Acetamide Derivatives as P2X7 Antagonists for the Treatment of Pain, Inflammation and NeurodegenerationBESWICK PAUL JOHN·Filed 2007·Application pending·0 cites
- 2742US10934272B2Pyridyl derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 2, 2021·0 cites·9 claims
- 2841US10471050B22-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Nov 12, 2019·0 cites·21 claims
- 2941US8846709B27-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1H-imidazo[4,5-C]quinoline derivativesDEMONT EMMANUEL HUBERT·Filed 2012·Granted Sep 30, 2014·0 cites·13 claims
- 3040US10844015B2Pyridine dicarboxamide derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Nov 24, 2020·0 cites·12 claims
- 3136US2008255358A1Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal DiseasesBAMFORD MARK JAMES·Filed 2006·Application pending·0 cites
- 3228US2012101083A1S1p1 agonists comprising a bicyclic n-containing ringBAILEY JAMES MATTHEW·Filed 2010·Application pending·0 cites
- 3328US2012094979A1Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonistsBAILEY JAMES MATTHEW·Filed 2010·Application pending·0 cites
- 3427US2012101086A1Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptorsBAILEY JAMES MATTHEW·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emmanuel Hubert Demont files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →